Hidradenitis Suppurativa and Skin Cancer

What You Should Know About Hidradenitis Suppurativa and Skin Cancer

What You Should Know About Hidradenitis Suppurativa and Skin Cancer
Adobe Stock
People with hidradenitis suppurativa (HS), an inflammatory skin condition that causes painful, deep-seated abscesses in skin folds, are usually well aware of other health problems it can cause.

 Permanent scarring, as well as depression and anxiety brought on by living with a chronic, visible disease, are a few examples.

There’s one potential complication of HS that isn’t so well known, though: squamous cell carcinoma (SCC). It’s a small risk, but one worth being aware of.

If you’re living with HS, one of your best defenses against any complication is to learn all you can about it and use that information to fine-tune how you manage your condition. Here’s what you should know about the connection between HS and skin cancer.

What Is Squamous Cell Carcinoma?

Squamous cell skin cancers are malignant nonmelanoma growths that arise from a type of skin cell located in the outer and middle layers of the skin.

 After basal cell carcinoma, SCC is the second most common skin cancer. It’s typically caused by excessive exposure to ultraviolet (UV) rays.
Squamous cell cancer is highly curable as long as it’s diagnosed and treated promptly.

 Around 2,000 to 8,000 people in the United States die each year from basal and squamous cell cancers combined, mostly from SCC.

“If left untreated, squamous cell cancer can become locally invasive, aggressive, and destructive to the skin and nearby tissue,” says Farah Succaria, MD, an assistant professor of dermatology at Johns Hopkins University School of Medicine in Baltimore. In other words, it can metastasize (spread) and cause serious and potentially fatal damage.­

What Makes SCC Different in Hidradenitis Suppurativa?

Again, SCC is most often caused by too much sun exposure. This may sometimes be the case for people with HS who develop SCC in areas of skin that aren’t typically hidden in skin folds or by clothing. Other factors, including chronic inflammation and immunosuppression, may also play a role in how squamous cell cancer occurs and behaves when it’s associated with HS.

A chief concern is inflammation, which can make any type of cancer worse, says Luis Andres Garza, MD, PhD, a professor of dermatology at Johns Hopkins University School of Medicine in Baltimore. The inflammation that happens in the body from HS may be part of the increased likelihood of squamous cell skin cancer, he adds.

Certain treatments for HS may ratchet up the risk of SCC. Some HS medications suppress the immune system, for example, which is linked to a higher risk of developing skin cancer, says Dr. Garza. One study, for example, found that immunosuppression is an independent risk factor associated with worse outcomes in those who have cutaneous, or skin-based, squamous cell carcinoma.

Another unique factor of squamous cell carcinoma in HS is location. “HS primarily occurs in places where skin rubs on skin,” says Rita Pichardo, MD, a dermatologist at Atrium Health Wake Forest Baptist in Winston-Salem, North Carolina, who runs an HS clinic. “These regions can be chronically inflamed for many years. That makes certain regions in the body — the vulvar, perianal, and perineal areas — especially prone to developing skin cancer.”

A review of studies published in 2021 looked at SCC as a result of HS and found that the most common sites of the cancer were the buttocks, the perianal region, and the genitals.

SCC may also be more likely to spread and even cause death in people with HS than in otherwise healthy people. In the 2021 review, for instance, in more than half of the people (mostly male) with HS who developed squamous cell growths, the cancer metastasized. Over 40 percent of them had a recurrence of SCC, and more than 58 percent ultimately died, most commonly of metastases or sepsis.

Lastly, chronic wounds — like the persistent lesions that characterize HS — are associated with a type of skin cancer that frequently takes the form of squamous cell carcinoma, adds Garza. Known as Marjolin’s ulcer, this rare, aggressive skin cancer develops in scar tissue, chronic ulcers, and areas affected by inflammation.

Catching SCC Early

Squamous cell carcinoma may be particularly problematic in HS, because the lesions caused by the two conditions look similar, so skin cancer may be overlooked, suggests a review of research on certain cancers in HS patients.

For this reason, it’s especially important for people with HS to see a dermatologist every 6 to 12 months for a full-body cancer screening, says Dr. Pichardo. Even then, “It can be difficult, even for a doctor, to spot skin cancer just by looking at it,” notes Garza, “so we’ll perform a biopsy on anything we find that’s concerning.”

Self-exams between skin checks are also a good idea. About once a month, examine your skin, using a mirror for areas you can’t see otherwise, to look for anything that seems different or unusual, advises Garza. “Trust your intuition,” he adds. “If something looks weird or you’ve never noticed it before, bring it to the attention of your doctor.”

Some specific symptoms to look for: “A place on your skin that bleeds by itself is a red flag,” says Garza. It’s not uncommon for people who have HS to notice pus or even blood coming out of their skin, but since bleeding can be a nonspecific sign of skin cancer, it needs to be checked out by your dermatologist.

Additionally, within an area of HS lesions that are improving with treatment, if there’s one that won’t go away or looks unusual, talk to your doctor, says Garza.

Tips for Preventing Skin Cancer

There are several simple ways to keep the already small risk of skin cancer associated with HS to an absolute minimum.

Get diagnosed as soon as possible. If you have symptoms of HS, such as a painful nodule that looks like a cyst or a boil in your armpit, inner thigh, or groin, see a dermatologist right away. The sooner you start treatment, the less inflammation you’ll experience over time.

Follow your management plan to a T. “There are no studies that show with certainty whether or not managing HS well can reduce associated skin cancer risk, but it’s probably the case,” says Garza.

Prevent sunburn. This means staying out of the direct sun when possible, wearing sunglasses and a hat with a brim, and using sunscreen on exposed skin, even on cloudy days

— but not on HS lesions. Though skin cancers generally occur most often in areas touched by the sun, in HS, it is more likely to be located in parts of the body that are covered or hidden. Clothing with built-in SPF is an option for areas with active lesions. Most importantly, says Garza, “If you have HS, it’s good to be aware of the skin cancer risk so that you can be on the lookout and see your dermatologist regularly, but I recommend focusing on your overall health. That includes managing your disease and maintaining a healthy diet and overall healthy lifestyle.”

The Takeaway

  • People living with hidradenitis suppurativa face a higher risk of skin cancer, particularly squamous cell carcinoma, than the rest of the population.
  • Though this elevated risk is small, experts advise early diagnosis and treatment, followed by regular skin cancer screenings every 6 to 12 months.
  • While the reasons for increased rates of skin cancer in HS are not fully understood, research shows that inflammation and immunosuppressive treatments may be associated.
  • Proactive measures, such as getting diagnosed early and using layered sun protection, can reduce cancer-related risks in people who have hidradenitis suppurativa.
Jacquelyn Dosal

Jacquelyn Dosal, MD

Medical Reviewer

Jacquelyn Dosal, MD, is a board-certified dermatologist practicing at The Dermatology House in Park City, Utah. Her areas of expertise include acne, rosacea, integrative treatments of inflammatory skin diseases, as well as laser treatment of the skin and injectables.

Dr. Dosal writes cosmetic questions for the certifying exams for the American Board of Dermatology. She is also the deputy editor for the American Academy of Dermatology's podcast, Dialogues in Dermatology.

Becky Upham, MA

Becky Upham

Author

Becky Upham has worked throughout the health and wellness world for over 25 years. She's been a race director, a team recruiter for the Leukemia and Lymphoma Society, a salesperson for a major pharmaceutical company, a blogger for Moogfest, a communications manager for Mission Health, a fitness instructor, and a health coach.

Upham majored in English at the University of North Carolina and has a master's in English writing from Hollins University.

Upham enjoys teaching cycling classes, running, reading fiction, and making playlists.

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Hidradenitis Suppurativa (HS). Tufts Medicine.
  2. Hidradenitis Suppurativa. MedlinePlus.
  3. Gierek M et al. Hidradenitis suppurativa and squamous cell carcinoma: A systematic review of the literature. Advances in Dermatology and Allergology. April 21, 2023.
  4. Squamous Cell Carcinoma of the Skin. Mayo Clinic. August 11, 2023.
  5. Squamous Cell Carcinoma Overview. Skin Cancer Foundation.
  6. Key Statistics for Basal and Squamous Cell Skin Cancers. American Cancer Society. October 31, 2023.
  7. Tam S et al. Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Otolaryngology–Head & Neck Surgery. December 5, 2019.
  8. Sachdeva M et al. Squamous cell carcinoma arising within hidradenitis suppurativa: A literature review. International Journal of Dermatology. June 2, 2021.
  9. Marjolin’s Ulcer. Dermatology for the Primary Care Provider. 2022.
  10. Li Pomi F et al. Neoplastic Implications in Patients Suffering from Hidradenitis Suppurativa under Systemic Treatments. Biomedicines. November 1, 2021.
  11. Roustan G. Hidradenitis Suppurativa: Need for Early Diagnosis and Management of the Disease and Associated Conditions. Actas Dermo-Sifiliográficas. May 2019.
  12. Young AR et al. Patient Education: Sunburn Prevention (Beyond the Basics). UpToDate. November 2024.